Cipla Limited (CIPLA) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Total Cash From Operating Activities Chart for Cipla Limited

Cipla Limited (CIPLA) operating cash flow for FY2026 was INR 41.3B, a -17.6% change from FY2025. Cipla Limited's operating cash flow grew from INR 2.5B in 2004 to INR 41.3B in 2026 (1542.1% over 22 years). Operating cash flow compound annual growth rate: 5-year CAGR of 1.9%, 10-year CAGR of 9.0%, 20-year CAGR of 14.5%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.